Si necesita ayuda en español, por favor comuníquese por teléfono al 800-438-4380 o por correo electrónico con el Centro de Educación y Referencias sobre la Enfermedad de Alzheimer y las Demencias Relacionadas (ADEAR, por sus siglas en inglés).
October 27 – 28, 2021
10:00am – 3:00pm EDT
This live, virtual symposium will feature an array of NIA-supported translational research programs that employ precision medicine principles and open-science practices to:
The symposium program will feature scientific advances and translational infrastructure resources developed by the: Accelerating Medicines Partnership® for Alzheimer’s Disease (AMP AD), the Alzheimer’s Gut Microbiome Project (AGMP), MODEL- AD Consortium, TREAT- AD Centers, the Alzheimer’s Biomarkers Consortium - Down Syndrome (ABC-DS) and other consortia.
While all are welcome, this symposium is designed for academic, biotech and pharmaceutical industry researchers with an interest in target and biomarker discovery, preclinical and clinical drug development. Other groups who may be interested include computational biologists, data scientists, and open science advocates.
Use this link to register for this free symposium.
10:00am – 11:30am: Session 1 | AMP AD: Precision Medicine Approach to Novel Target and Biomarker Discovery
Co-Chairs: Nilüfer Ertekin-Taner, Mayo Clinic and Matthias Arnold, Helmholtz University
Speakers:
11:10am – 11:30am: Session 1 Q&A
11:30am – 11:45am: Break
11:45am – 1:15pm: Session 2 | MODEL-AD Consortium: A Precision Medicine Approach to the Development of Animal Models of Late Onset AD and Preclinical Efficacy Testing
Co-Chairs: Bruce Lamb, Indiana University and Andrea Tenner, University of California, Irvine
Speakers:
12:55pm – 1:15pm Session 2 Q&A
1:15pm – 1:30pm Break
1:30pm – 3:00pm: Session 3 | TREAT-AD Centers: Expanding the AD Target Landscape and Accelerating Drug Discovery for Novel Targets
Co-Chairs: Alan Palkowitz, Indiana University and Lara Mangravite, Sage Bionetworks
Speakers:
2:40pm – 3:00pm: Session 3 Q&A
10:00am – 11:30am: Session 4 | Alzheimer’s Gut Microbiome Project
Co-Chairs: Rima Kaddurah-Daouk, Duke University and Sarkis Mazmanian, California Institute of Technology
Speakers:
11:10am – 11:30am: Session 4 Q&A
11:30pm – 11:45pm: Break
11:45am – 1:15pm: Session 5 | Impact of Sex Differences on the Molecular Determinants of AD Risk and Resilience and Responsiveness to Treatment
Co-Chairs: Catherine Kaczorowski, The Jackson Laboratory and Susan Catalano, Cognition Therapeutics
Speakers:
12:55pm – 1:15pm: Session 5 Q&A
1:15pm – 1:30pm: Break
1:30pm – 3:00pm: Session 6 | Precision Medicine Cohorts and Consortia: ABC-DS, HABS-HD, LEADS
Co-Chairs: Sid O’Bryant, University of North Texas Health Science Center and Liana Apostolova, Indiana University
Speakers:
2:40pm – 3:00pm: Session 6 Q&A
Un sitio web oficial del Gobierno de los Estados Unidos, gestionado por el Instituto Nacional sobre el Envejecimiento, parte de los Institutos Nacionales de la Salud